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Stenotrophomonas maltophilia is increasingly identified as an opportunistic pathogen in
immunocompromised, cancer and cystic fibrosis (CF) patients. Knowledge on innate
immune responses to S. maltophilia and its potential modulation is poor. The present
work investigated the ability of 12 clinical S. maltophilia strains (five from CF patients,
seven from non-CF patients) and one environmental strain to survive inside human
monocyte-derived dendritic cells (DCs). The effects of the bacteria on maturation of and
cytokine secretion by DCs were also measured. S. maltophilia strains presented a high
degree of heterogeneity in internalization and intracellular replication efficiencies as well as
in the ability of S. maltophilia to interfere with normal DCs maturation. By contrast, all S.
maltophilia strains were able to activate DCs, as measured by increase in the expression
of surface maturation markers and proinflammatory cytokines secretion.
Keywords: DC maturation markers, cytokines secretion, cystic fibrosis, opportunistic pathogen, innate immune
response
Introduction
The environmental Gram-negative bacillus Stenotrophomonas maltophilia is increasingly
identified as an opportunistic nosocomial pathogen for susceptible individuals, including
immunocompromised, cancer, and cystic fibrosis (CF) patients (Brooke, 2012; Waters et al., 2013).
Cases of community-acquired S. maltophilia infections have also been reported (Falagas et al.,
2009b; Chang et al., 2014). Molecular analyses have revealed considerable heterogeneity among S.
maltophilia isolates, including those coming from just one hospital (Roscetto et al., 2008; Kaiser
et al., 2009; Rocco et al., 2009).
The intrinsic resistance to a wide spectrum of antibiotics (Crossman et al., 2008; Brooke, 2014),
the ability to adhere and form biofilm on medical devices surfaces and airway epithelial cells
(Pompilio et al., 2010), make S. maltophilia responsable of persistent nosocomial infections. S.
maltophilia can cause various serious infections but it is most commonly associated with pneumonia
(Weber et al., 2007; Chang et al., 2014; Chawla et al., 2014). S. maltophilia pneumonia may be
complicated by persistent bacteremia associated with a significant increased mortality (Elsner et al.,
1997; Falagas et al., 2009a).
Little is known about pathogenesis of S. maltophilia, and the genomic diversity exhibited by
clinical isolates makes difficult the identification of pathogenic traits. Factors likely involved in
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TABLE 1 | Stenotrophomonas maltophilia strains used in DC infection assay.
Strain name Source Swimming motility Twiching motility Biofilm production
CF1545 Sputum (P) ++ + ++
CF781 Sputum (G) ++ + ++
CF635 Sputum (P) – – –
CF2315 Sputum (G) + +++ ++
CF1445 Pharyngeal aspirate (P) + ++ ++
NCF879 Sputum (ICU) +++ +++ +++
NCF1489 Sputum (H) +++ +++ +++
NCF1732 Bronchial aspirate (ICU) +++ +++ +++
NCF1376 Bronchial aspirate (ICU) ++ ++ +
NCF2035 Bronchial aspirate (ICU) ++ +++ +++
TFE66 Foot wound swab (D) +++ ++ +++
K279a Blood infection ++ + ++
LMG11104 Tuberous roots ++ ++ ++
P, Pediatrics; G, Geriatrics; ICU, Intensive Care Unit; H, Hematology; D, Diabetology; LMG-labeled strain is from the Laboratorium voor Microbiologie Gent Culture Collection, Belgium.
(+, weak; ++, moderate; +++, strong).
the pathogenesis of S. maltophilia have been described (Chhibber
et al., 2008; Pompilio et al., 2011; Roscetto et al., 2012). The
ability to adhere and penetrate inside airway epithelial cell
lines (Pompilio et al., 2010), and stimulate robust cytokine
production in macrophages and monocytes are key steps in S.
maltophilia infections (Waters et al., 2007; Härtel et al., 2013).
Little is known on the interactions between S. maltophilia and
dendritic cells (DCs). Immature DCs (iDCs) are sentinel cells
found in skin, respiratory and gastrointestinal mucosae constantly
recruited from blood to peripheral tissues, even in the absence
of inflammatory processes (Guermonprez et al., 2002). Upon
capture of soluble antigens or bacteria, iDCs undergo maturation,
a profound change in gene expression transforming them from
antigen-capturing to mature antigen-processing and -presenting
cells (Guermonprez et al., 2002; Villadangos and Health, 2005).
Mature DCs migrate to secondary lymphoid organs to prime
naïve T cells differentiation into effector T cells (Reis e
Sousa, 2006). DCs produce interleukin-12p70 (IL-12p70), which
activates the differentiation of T helper 1 (Hsieh et al., 1993)
and cytotoxic T cells, and IL-1 beta, IL-6, and IL-23, required
for differentiation of Th17 cells (Acosta-Rodriguez et al., 2007).
Pathogenic bacteria have developed strategies which enable
them to escape phagocytosis and killing by DCs, or affect DC
maturation (Bueno et al., 2012).
The aimof this studywas to compare the ability of S.maltophilia
strains from CF and non-CF patients to survive in human
monocyte-derived DCs, and evaluate whether isolates from CF
patients have unique properties. We also examined the effect of
S. maltophilia strains on the maturation of DCs, monitoring the
expression of specific maturation markers by flow cytometry.
Materials and Methods
Bacterial Strains and Culture Conditions
Thirteen non-clonal clinical isolates of S. maltophilia were
included in the study. Strains were isolated from diverse clinical
settings, including CF and non-CF respiratory specimens, as
well as non-respiratory specimens, collected at the Laboratory
of Clinical Microbiology, University Federico II of Naples.
The sequenced strain K279a was kindly provided by M. B.
Avison (University of Bristol, Bristol, UK). The environmental
strain LMG11104 was obtained from the BCCM (Belgium
Coordinated Collections of Microorganisms/Laboratorium) voor
Microbiologie Ghent, University of Ghent, Belgium. Details of the
bacterial strains used in this study are given in Table 1. Bacteria
were identified as S. maltophilia by biochemical characteristics
and antibiotic resistance analysis, using the VITEK II system
(bioMerieux) and confirmed by MALDI TOF MS (Bruker).
Bacteria were grown overnight at 37°C for 24 h in Brain-Hearth
Infusion broth (BHI; BectonDickinson), and aliquots were frozen
in BHI-glycerol at 80°C until use.
Motility Assays
Swimming motility was evaluated on plates 1% tryptone, 0.5%
NaCl containing 0.3% agar. A colony of bacteria was inoculated
with a sterile toothpick placed directly into the center of the agar.
After incubation for 48 h at 30°C, the diameters of the swimming
motility zones were measured. Twitching motility was evaluated
on plates 1% tryptone, 0.5% yeast extract, 0.5% NaCl containing
1% agar. A colony of bacteria was inoculated deep into the agar
with a sterile toothpick at the bottom of twitch plates. After
incubation at 37°C for 24 h, the zone of motility at the agar-petri
dish interface was measured by staining with 1% crystal violet.
Biofilm Assay
Biofilm formation was tested in 96-well microtiter plates
according to Stepanovic et al. (2000). Briefly, one colony of the
overnight cultures of bacterial strains was diluted in trypticase
soy broth (TSB) in order to adjust the turbidity of the bacterial
suspension to 0.5 McFarland standard, approximately 108 CFU
(colony forming units)/mL. Bacterial suspension was diluted
1:100 in TSB and 200mL of the diluted bacteria was added to each
well. Negative control wells contained broth only. The plates were
incubated aerobically for 48 h at 37°C. Thereafter, the content of
each well was aspirated and the wells washed three times with
300 ml of sterile phosphate buffered saline (PBS). Biofilm was
fixed incubating microtiter plates for 1 h at 60°C. The plates
were stained with 30 ml per well of 1% crystal violet for 15 min
and washed with 150 ml of sterile PBS. The dye bound to the
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adherent cells was resolubilized with 150 ml of 95% ethanol per
well. The optical density of each well was measured at 630 nm
using a microplate reader (Biorad). Based on the optical densities
of bacterial biofilms, all strains were classified into the following
categories: no biofilm producers ( ), weak (+), moderate (+),
or strong (+++) biofilm producers, as previously described
(Stepanovic et al., 2000).
In vitro Generation and Culture of Human DCs
Immature dendritic cells were generated from peripheral blood
mononuclear cells, as described (Sallusto and Lanzavecchia,
1994). Briefly, peripheral blood mononuclear cells were
obtained from 30 ml of leukocyte-enriched buffy coat from
healthy donors by centrifugation on a Ficoll-Hypaque plus
(GE Healthcare) through density gradient. Monocytes were
purified by positive selection using anti-CD14 mAb-conjugated
magnetic microbeads (Miltenyi Biotec). CD14+ cells were
cultured in RPMI 1640 supplemented with 10% fetal calf serum
(Invitrogen), and 2 mM glutamine (Invitrogen) containing
50 ng/ml GM-CSF (granulocytes monocytes-colony stimulating
factor) and 250 ng/ml IL-4 (Immunotools). Cells were cultured
for 5–7 days in 5% CO2 atmosphere to obtain a population of
iDCs. Purity of generated DCs was checked by flow cytometry,
using Phycoerythrin (PE) conjugated anti-CD1a antibody
(Becton Dickinson) on a FACScalibur flow cytometer (Becton
Dickinson). DC populations were used when CD1a expression
was > 95%. Written informed consent was obtained from
each donor at the time of venous peripheral blood donation,
in accordance with the Declaration of Helsinki, as approved
by Azienda Ospedaliera Universitaria Federico II. All the
experiments done by using blood donations were performed and
analyzed anonymously, without any biographical reference to
donors.
DC Infection Assays
iDCs were seeded at a concentration of 106 cells per well into 24-
wells culture plates, infected with 2  107 CFU/ml of mid-log
growth phase S. maltophilia cells to yield bacterium-to-dendritic
cell ratio of 20:1 and incubated for 1 h at 37°C in 5% CO2.
To assess the number of intracellular bacteria, the culture
medium was gently removed, cells were washed twice with
sterile PBS and further incubated for 1 h in fresh medium
containing 600 mg/ml gentamicin or 1 mg/ml ceftazidime to
kill extracellular bacteria. DCs were subsequently washed and
incubated in 10mMEDTA, 0.25%Triton X-100 (Sigma) for 5min
to release internalized bacteria. Lysates were serially diluted 1:10
and plated on TSA (Becton Dickinson) to quantify the number of
viable intracellular bacteria. Entry Index (EI), i.e., the percentage
(mean) of the inoculated CFUs that were internalized by iDCs
after 1 h of infection, was determined as follows: EI= (CFUml 1
recovered from DCs after 1 h of infection/CFU ml 1 applied to
DCs) 100.
To measure intracellular replication, after infection of DCs
with S. maltophilia and antibiotic treatment cells were extensively
washed and fresh medium was added. Incubation was continued
for additional 16 h. After washing three times with PBS,
intracellular bacteria were released by addition of 10 mM EDTA,
0.25% Triton X-100 and the number of CFU was determined
by plating 10-fold dilutions on TSA. Intracellular Replication
Index (RI), i.e., the percentage (mean) of the internalized CFUs
that survived by iDCs after 18 h of infection, was determined
as follows: RI = (CFU ml 1 recovered from DCs after 18 h
of infection/CFU ml 1 recovered from DCs after 1 h of
infection) 100.
The bactericidal activity of gentamicin or ceftazidime at
the used concentrations had been previously assessed. The
effectiveness of drugs during infection assays was tested by
supernatant sampling before DCs lysis and plating on TSA (data
not shown).
DCs Maturation Analysis
Dendritic cells were seeded in 24-well plates at a concentration of
106 cells/ml and then exposed to RPMI 1640 only, 1 mg/ml LPS
or live bacteria at anMOI of 20:1. After 18 h of incubation at 37°C
and 5% CO2, DCs were harvested, washed, re-suspended in FACS
buffer and DC maturation was then analyzed measuring CD86
and CD80 expression by flow cytometry, using FITC-conjugated
anti-CD80 antibody and a PE-conjugated anti-CD86 antibody
(Becton Dickinson).
For TNFa expression, cells were cultured for 2 h with the
bacterial strains in the presence of 5 mg/ml Brefeldin A (Sigma)
and then stained with anti-TNFa antibody (Becton Dickinson)
using Cytofix/Cytoperm method (Becton Dickinson), according
to manufacturer’s instructions. IL -12p70 production by DCs was
measured from supernatants using OptEIA ELISA kits (Becton
Dickinson), according to manufacturer’s instructions.
Statistical Analysis
All assays were performed in three independent experiments.
Paired Student’s t-test was used to evaluate the statistical
differences between uninfected-DCs and S. maltophilia-infected
DCs and between CFUs recovered from DCs after 1 h and after
17 h of incubation for each analyzed strain. Statistical differences
between multiple groups of S. maltophilia strains were assessed
using a Mann-Whitney non-parametric test. Values of p < 0.05
were taken as statistically significant differences.
Results
Internalization and Intracellular Replication of S.
maltophilia in Immature Monocytes-derived
Dendritic Cells
We have selected 13 strains from diverse clinical setting (Table 1).
Some were isolated from the respiratory tract of CF patients
(group 1, CF strains), others from the respiratory tract of non-
CF patients (group 2, NCF strains), the remaining from non-
respiratory specimens (group 3, NR strains). Motility is crucial
both to colonize an environment and to induce formation
of structured surface-associated communities of bacteria called
biofilm. For each strain, both motility and the ability to form
biofilm in polystyrene microtiter plates were analyzed. All CF and
NR strains exhibited reduced swimming and twiching motilities
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FIGURE 1 | Interactions of S. maltophilia strains with iDCs. White and gray bar graphs indicate CFUs recovered by iDCs after 1 h and 18 h of infection,
respectively. *p < 0.05. Each bar indicates the mean value  standard deviation of at least three independent experiments in triplicate.
compared to NCF strains (Table 1). Biofilm forming ability
greatly varied among strains tested (OD630 range: 0.08–1.2). Most
CF strains (80%) were moderate biofilm producers, whereas
the majority of the NCF and NR strains (75%) were strong
producers (Table 1). Strong biofilm producers exhibited increased
swimming and twitching activity.
The uptake and intracellular replication were analyzed by
infecting immature monocytes-derived DCs (iDCs) with tested S.
maltophilia strains at a MOI of 20. All strains were internalized
and were able to survive within iDCs, but internalization and
replication significantly varied among strains of the same group,
as among strains of different groups (Figure 1). The difference
between CFUs at 1 h and 18 h of infection resulted statistically
significant (p< 0.05) for 11/13 strains (Figure 1). Values of Entry
Index (EI) of CF strains ranged from 1.35 for (CF1445 strain) to
4.6 (CF1545 strain; Figure 2A). Only the CF781 strain was able
to grow intracellularly (p < 0.05) with Intracellular Replication
Index (RI) of 166.7 (Figure 2B). EI values of NCF strains ranged
from 1,6 (NCF 1489 strain) to 14.38 (NCF2035 strain; Figure 2A).
Two NCF isolates (NCF879 and NCF2035 strains) were able to
multiply intracellularly (p < 0.05) with RI mean values of 140.38
and 170.83 respectively (Figure 2B). Among NR strains, only the
K279a strain could survive into iDCs, but was unable to replicate,
because no significant differences (p= 0,27) between CFUs at 1 h
and 18 h were found (Figure 1). In spite of the limited number
of clones analyzed, no significative difference could be observed
among CF, NCF, and NR strains. This weakens the hypothesis
made by several groups suggesting that unique properties may be
associated to CF strains (see Waters et al., 2007).
S. maltophilia Induces DCs Maturation
Changes induced in DCs by tested strains were assessed by
measuring by flow cytometry the expression of CD86 and CD80,
two costimulatory molecules upregulated during DC maturation.
As revealed by the fold increase in mean fluorescence intensity
(MFI) of CD80 and CD86 (Figure 3), most strains induced a
consistent upregulation of both molecules. Only for the NCF2035
strain no statistically significative difference in the expression of
both CD80 and CD86 in infected and uninfected cells could be
observed.
Along with changes in the expression of surface maturation
markers, DC secrete several cytokines in response to intracellular
infection. All strains induce a statistically significative (p< 0.001)
increase of TNFa and IL-12 cytokines (Figure 4). Also in DCs
maturation, no significant differences (p> 0.05) was observed by
comparing CF isolates to either NCF or NR strains.
Discussion
By sensing danger signals in peripheral tissues, iDCs activate
both adaptive and innate immunity, leading to bacterial clearance.
Several microbial pathogens are able to avoid or subvert
DCs, thwarting DC differentiation, survival, maturation, antigen
processing and presentation and the induction of T cell immunity
(Rescigno, 2015). This is the first report of the interaction
between human monocyte-derived DCs and S. maltophilia. All
the analyzed strains were internalized by DCs (Figure 1), but
the efficiency of internalization and intracellular survival differed
highly (Figure 2). Six of thirteen strains exhibited low EI values,
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FIGURE 2 | DC infection assays. (A) Entry Index (EI). Bar graphs shown the
percentage internalization of S. maltophilia strains after 1 h of infection with DCs.
(B) Intracellular Replication Index (RI). Bar graphs shown the percentage survival
of S. maltophilia strains after 18 h of infection within DCs. Each bar indicates the
mean value  standard deviation of at least three independent experiments in
triplicate.
FIGURE 3 | Stenotrophomonas maltophilia strains induce
dendritic cells maturation. Bar graphs shown the fold change in
CD80 (A) and CD86 (B) expression after 18 h of incubation. CD86
and CD80 expression on DCs was measured by flow cytometry.
The mean fluorescence intensity (MFI) reflects the upregulation of
molecule on cell surface. Each bar indicates the mean  standard
deviation of three independent experiments. *p < 0.05. Medium:
iDCs uninfected.
FIGURE 4 | Stenotrophomonas maltophilia strains induce cytokines
production by dendritic cells. Bar graphs shown the production of IL-12
(A) and TNFa (B) by dendritic cells after incubation with the S. maltophilia
strains. IL-12 and TNFa expression by DCs was measured by ELISA and
flow cytometry, respectively. Each bar indicates mean  standard
deviation of at three independent experiments. All the bacterial strains
induced the production of TNFa and IL-12 by DCs (p < 0.001). Medium:
iDCs uninfected.
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and were unable to persist inside host cells. Thus, these S.
maltophilia isolates plausibly escape the effector cells of innate
immunity by circumventing phagocytosis. Four strains showed
high EI values, and two (NFC879 and NFC2035) also exhibited
high RI values. NFC879- and NFC2035-like strains could safely
be mobilized in the host evading antimicrobial therapy and
immune response. The intracellular survival and replication could
contribute to S. maltophilia virulence, and DCs may serve as
dissemination vectors of bacteria outside of the infection site.
Monitoring changes in gene expression occurred in bacteria
recovered by DCs after 1 h and 18 h of infection could eventually
help to clarify the intracellular survival strategy of S. maltophilia
inside DCs.
Most of tested strains induced a significant increase in the
expression of DC surface maturation markers (Figure 3). This
suggests that DCs exposed to S. maltophilia can prime naïve
T cells. Noteworthy, the NFC2035 strain, which exhibited the
highest RI value, selectively failed to upregulate CD80 and CD86
costimulatory molecules. Pathogens as diverse as Mycobacterium
tuberculosis, HIV-1, and Leishmania sp., downregulate the
expression of costimulatory molecules in order to establish
chronic infection. Impairment in the signaling events delivered
by costimulatory molecules may be responsible for defective T-
cell responses, enabling infective organisms to grow unhindered
in the host cells (Khan et al., 2012).
All tested strains were able to induce the production of TNFa
and IL-12 in DCs (Figure 4), and this is on line with data obtained
by monitoring the response of macrophages to S. maltophilia
(Waters et al., 2007). The production of both cytokines may play
a crucial role in tissue inflammation, and contribute to a slow
damage in CF lung. Clinical retrospective studies indeed showed
deterioration of lung function after prolonged colonization with
S. maltophilia in CF- as in hospital-acquired pneumonias (Karpati
et al., 1994).
No significant difference was observed in the maturation of
iDCs stimulated with S. maltophilia strains belonging to CF,
NCF, and NR group. The data suggested that internalization,
intracellular survival and immunostimulatory properties of S.
maltophilia are strain-dependent. This is in accord with studies
showing that different S. maltophilia strains replicate and persist
in the murine lungs to significantly different degrees (Rouf
et al., 2011). The observed heterogeneity is not surprising, in
light of the high genetic diversity exhibited by S. maltophilia
isolates (Roscetto et al., 2008; Kaiser et al., 2009; Rocco et al.,
2009).
Further experiments will be needed to characterize the DC-
driven T-cell responses, analyzing the ability of DCs infected with
S. maltophilia to bias naive allogenic T-cell differentiation toward
a TH1 or TH2 phenotype.
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